BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

BIOLASE Technology, Inc. (BIOL) Awarded New Patent for Delivering Sterile Water


7/30/2013 9:12:24 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

IRVINE, CA--(Marketwired - July 30, 2013) - BIOLASE, Inc. (NASDAQ: BIOL), the world's leading manufacturer and distributor of dental lasers, and a pioneer in laser surgery in other medical specialties, announced today that the U.S. Patent and Trademark Office ("USPTO") has issued BIOLASE® a new patent for delivering sterile water. This new patent significantly expands on BIOLASE's fluid conditioning system technology which is already covered in several issued U.S. patents. Currently, BIOLASE holds over 180 issued patents in the field of medical and dental laser technology, with several new patent applications pending world-wide.

U.S. Patent No. 8,485,818 is titled "Fluid Controller" and relates to a new controlled way of delivering sterile water within the fluid conditioning system of BIOLASE's revolutionary WaterLase® systems. This technology will be used in both dental and medical cutting, irrigating, evacuating, cleaning and drilling operations. An additional important aspect of this new patent is the introduction of disinfectant agents via spray, mist, or water stream used for dental or surgical applications.

Dmitri Boutoussov, Vice-President of Research and Development commented, "The effectiveness and accuracy of WaterLase technology for clinical applications is critically dependent on the extremely precise control of the fluid flow. It is a core competency at BIOLASE and key area of differentiation for us over all other hard-tissue lasers in the market. It is challenging to precisely control fluids at very low flow levels. Inkjet printers and fuel injection systems are good examples of successful products in other industries. Our ability to meet these challenges expands our ability to leverage this technology into our targeted non-dental medical markets where the use of sterile fluids is mandatory."

"Off-the-shelf solutions were not able to meet our exacting requirements, which motivated us to develop a whole new approach to precisely control fluid flow with an integrated sterile and disposable design. Success in practical implementation of our concept will open doors for new medical applications of our laser technology," concluded Boutoussov.

Federico Pignatelli, Chairman and Chief Executive Officer, said, "This is an exciting patent for BIOLASE. This latest patented technology is a departure from conventional fluid flow control systems and is expected to advance the efficacy and safety of laser related surgical procedures where sterile fluids are required. Further, while the ability to use the WaterLase for dental and medical indications requiring a sterile water system is a major advance, our IP in this patent family also covers fluid conditioning with disinfectants, flavors, antibiotics and other conditioned fluid particles which hold promise for future applications."

This is the fifth U.S. patent issued in relation to groundbreaking fluid conditioning laser technology with an additional U.S. patent application pending.

About BIOLASE, Inc.
BIOLASE, Inc. is a biomedical company that develops, manufactures, and markets innovative lasers in dentistry and medicine and also markets and distributes high-end 2D and 3D digital imaging equipment and CAD/CAM intraoral scanners; products that are focused on technologies that advance the practice of dentistry and medicine. The Company's proprietary laser products incorporate over 350 patented and patent-pending technologies designed to provide biologically clinically superior performance with less pain and faster recovery times. Its imaginative products provide cutting-edge technology at competitive prices to deliver the best results for dentists and patients. BIOLASE's principal products are revolutionary dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications, and a full line of dental imaging equipment. BIOLASE has sold more than 22,500 lasers. Other laser products under development address ophthalmology and other medical and consumer markets.

For updates and information on WaterLase and laser dentistry, find BIOLASE online at www.biolase.com, Facebook at www.facebook.com/biolaseinc, Twitter at www.twitter.com/biolaseinc, Pinterest at www.pinterest.com/biolase, LinkedIn at www.linkedin.com/company/biolase, Instagram at www.instagram.com/biolaseinc and YouTube at www.youtube.com/biolasevideos.

BIOLASE® and WaterLase® are registered trademarks of BIOLASE, Inc.


For further information, please contact:
Michael Porter
Porter, LeVay & Rose, Inc.
212-564-4700



Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES